IL-15 Enhanced NK Cell Therapy for Solid Tumors

Clinical trial NCT07621471 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07621471
Sponsor: Genovn Therapeutics (Suzhou) Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Solid Tumors Metastatic Cancer

Start date: 2026-07-01
Primary completion: 2028-12-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.